Exciting challenges ahead for integrative physiology

Frontiers in Physiology

Volumn 1 SEP, Issue , 2010, Pages

  Head, Geoffrey A ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865988391     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2010.000127     Document Type: Article

References (14)

1. Adams, D. J., Head, (equal first author) G. A., Markus, M. A., Lovicu, F. J., van der Weyden, L., Köntgen, F., Arends, M. J., Thiru, S., Mayorov, D. N., and Morris, B. J. (2006). Renin enhancer is critical for regulation of renin gene expression and control of cardiovascular function. J. Biol. Chem. 281, 31753-31761.
2. Bernstein, K. E. (2006). Views of the renin-angiotensin system: brilling, mimsy, and slithy tove. Hypertension 47, 509-514.
3. Boehr, D. D., McElheny, D., Dyson, H. J., and Wright, P. E. (2006). The dynamic energy landscape of dihydrofolate reductase catalysis. Science 313, 1638-1642.
4. Davern, P. J., and Head, G. A. (2007). Fos-related antigen immunoreactivity after acute and chronic angiotensin II-induced hypertension in the rabbit brain. Hypertension 49, 1170-1177.
5. Leung, P. S., and Sernia, C. (2003). The renin-angiotensin system and male reproduction: new functions for old hormones. J. Mol. Endocrinol. 30, 263-270.
6. Lew, R. A., Mustafa, T., Ye, S., McDowall, S. G., Chai, S. Y., and Albiston, A. L. (2003). Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP). J. Neurochem. 86, 344-350.
7. Moeller, I., Allen, A. M., Chai, S. Y., Zhuo, J., and Mendelsohn, F. A. (1998). Bioactive angiotensin peptides. J. Hum. Hypertens 12, 289-293.
8. Nishimura, H. (1978). Physiological evolution of the renin-angiotensin system. Jpn. Heart J. 19, 806-822.
9. Nishimura, H. (2001). Angiotensin receptors--evolutionary overview and perspectives. Comp. Biochem. Physiol., Part A Mol. Integr. Physiol. 128, 11-30.
10. Okuyama, S., Sakagawa, T., Sugiyama, F., Fukamizu, A., and Murakami, K. (1999). Reduction of depressive-like behavior in mice lacking angiotensinogen. Neurosci. Lett. 261, 167-170.
11. Raghavendra, V., Chopra, K., and Kulkarni, S. K. (1998). Modulation of motor functions involving the dopaminergic system by AT1 receptor antagonist, losartan. Neuropeptides 32, 275-280.
12. Raghavendra, V., Chopra, K., and Kulkarni, S. K. (1999). Brain renin angiotensin system (RAS) in stress-induced analgesia and impaired retention. Peptides 20, 335-342.
13. Takei, s Y., Joss, J. M., Kloas, W., and Rankin, J. C. (2004). Identification of angiotensin I in several vertebrate species: its structural and functional evolution. Gen. Comp. Endocrinol. 135, 286-292.
14. von Bohlen und Halbach, O., and Albrecht, D. (2006). The CNS renin-angiotensin system. Cell Tissue Res. 326, 599-616.